Canna Care Docs

OCTOBER 10, 2024

Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. What could the implications be for patients on their medical cannabis journey? Rescheduling would stand to have the largest impact on cannabis research and business taxes.

Patients 111

Patients DEA Research and Development Recreational 111

Cannabis Law Report

SEPTEMBER 1, 2021

The lawsuit—filed last year by cannabis researcher Sue Sisley of the Scottsdale Research Institute, the Battlefield Foundation and veterans Lorenzo Sullivan and Gary Hess— received oral arguments in June and largely centers on DEA’s 2020 denial of a one-page marijuana rescheduling petition filed by a separate individual.

DEA 109

DEA Marijuana Policy Cannabis 109

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. The BRC is among the dozens of organizations that have received preliminary approval from the DEA to cultivate cannabis. Shutterstock).

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

NORML

APRIL 30, 2024

“It is significant for these federal agencies, and the DEA and FDA in particular, to acknowledge publicly for the first time what many patients and advocates have known for decades: that cannabis is a safe and effective therapeutic agent for tens of millions of Americans.”

DEA 345

DEA Patients Cannabis Policy 345

MJ Business Attorneys

JUNE 29, 2018

Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. In the recent case Hemp Industries Associations v.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Canna Law Blog

JUNE 1, 2019

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Since then many different parties have tried to reschedule or end prohibition by filing petitions with DEA per the CSA protocol on rescheduling. That one was granted.

DEA 104

DEA Marijuana History Cannabis 104

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. In other words, the feds are ending their monopoly on cannabis grown for scientific purposes. cannabis researchers. cannabis researchers.

DEA 52

DEA Research and Development Data Cannabis 52

Canna Law Blog

SEPTEMBER 1, 2020

Last week the Drug Enforcement Administration (DEA) issued a bad interim hemp rule. North Carolina attorney Rod Kight raised these concerns as well and he and I both spoke to Kyle Jaeger of Marijuana Moment about why we think are concerned about the DEA’s interim hemp rule. Weekly in a phone interview.

DEA 93

DEA Hemp Seed-To-Sale THC 93

SpeedWeed

MAY 11, 2021

The annual DEA report also shows that federal law enforcement officers made nearly 5,000 cannabis-related arrests in 2020, a year wracked by the social and economic fallout of the Covid-19 pandemic. According to the data published in the DEA’s yearly Domestic Cannabis Eradication/Suppression Program Statistical Report, approximately 4.54

DEA 52

DEA Marijuana Data Programs 52

Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

Cannabis Law Report

AUGUST 24, 2020

August 24, 2020 The DEA has not issued a warning or otherwise signaled a change in enforcement policy by issuing the interim final rule. The post Duane Morris Article: DEA Issues Interim Final Rule Concerning Marijuana and Hemp first appeared on Cannabis Law Report. On … Read More.

DEA 59

DEA Hemp Marijuana Policy 59

The Blunt Truth

JULY 18, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 98

DEA Data Decriminalization Legalization 98

Canna Law Blog

FEBRUARY 9, 2024

Bush and his son didn’t do much to reform these dangerous and ineffective policies either. One of the most unexplainable and continuously disproven series of laws that the DEA have enforced for decades is the illogical Controlled Substances List. Worse even, both George H.W.

History 92

History DEA Policy Media 92

Veriheal

JANUARY 16, 2024

Although there have been rumors circulating for some time regarding the potential rescheduling of cannabis, it wasn’t confirmed until recently that this is becoming a genuine possibility. With cannabis’ current status as a Schedule I drug, it’s challenging for the federal government to push for nationwide legalization.

DEA 119

DEA Medicine Cannabis Legalization 119

WeedAdvisor

AUGUST 28, 2019

As we reported earlier , marijuana experts were frustrated over the poor quality of cannabis grown at the government’s only legal marijuana facility at the University of Mississippi. Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. Dozens of Applications”. .

DEA 61

DEA Marijuana History THC 61

CannaMD

MARCH 26, 2024

The recommendation by the FDA and HHS to reclassify marijuana as a Schedule III substance marks a pivotal shift in federal drug policy, acknowledging its medical benefits and potential for lower abuse.

DEA 96

DEA Marijuana Therapy Policy 96

SpeedWeed

MARCH 4, 2021

In the 2020 National Drug Threat Assessment , which was released by the DEA on Wednesday, the agency notes that despite its continued illegality under federal law, marijuana “is the most commonly used illicit drug in the United States.”. This has led to the saturation of some markets, particularly in states that have legalized cannabis.

DEA 52

DEA Supply Chain Advocacy Recreational 52

CannaMD

JULY 19, 2020

Drug Enforcement Agency (DEA) made far fewer cannabis-related arrests in 2019 than in previous years. At the same time, however, the number of illegal cannabis plants seized by the agency spiked. Let’s take a closer look at what DEA data reveals. Cannabis Users Left Alone. Illicit Grow Ops Targeted.

DEA 59

DEA Marijuana Data Decriminalization 59

NORML

MARCH 1, 2019

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” The agency said that the policy change was necessary because the existing system provided “no clear legal pathway for commercial enterprises to produce marijuana for product development.”

DEA 163

DEA Research and Development Clinical Trials Marijuana 163

SpeedWeed

MARCH 10, 2021

Well, the DEA just released its 2020 National Drug Threat Assessment, and the report is full of stats on the United States’ most popular illegal addictions, new trends in intoxicants, and foreign trade — a.k.a. The US sourced 92 percent of its heroin from Mexico in 2019, according to product analyzed by a DEA tracing program.

DEA 52

DEA Hemp Cannabinoids Legalization 52

NORML

JULY 15, 2020

Sixty-three percent of respondents also agreed, “The DEA should reclassify marijuana so that it is no longer a schedule I drug.". The post Survey: Majority of Health Care Professionals Endorse Cannabis Use Instead of Opioids in Chronic Pain Patients appeared first on NORML.

Chronic Pain 246

Chronic Pain Patients DEA Marijuana 246

Cannabis Law Report

SEPTEMBER 9, 2019

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45

DEA Law Policy Safety 45

Cannabis Law Report

FEBRUARY 22, 2023

Kaufman & Canoles The 2018 Farm Bill, officially known as the Agriculture Improvement Act of 2018, is a comprehensive piece of legislation that governs agricultural and food policy in the United States.

DEA 52

DEA THC Agriculture Law 52

Cannabis Law Report

JULY 20, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JULY 18, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

OCTOBER 21, 2021

A group of activists dressed in ape suits danced around an eight-foot monolith that they erected outside of the Drug Enforcement Administration (DEA) headquarters on Wednesday, calling on the agency to evolve its policies on marijuana and other controlled substances. It’s OK if you need to read that again. Read more at.

DEA 52

DEA Policy Cannabis Marijuana 52

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

JUNE 16, 2022

According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Program Statistical Report, agents and their partners confiscated approximately 5.53 million cultivated cannabis plants last year – a 20 percent increase over 2020’s totals. Federal law enforcement agents and their partners seized over 5.5

DEA 52

DEA Marijuana Programs Data 52

Cannabis Law Report

FEBRUARY 23, 2023

The 2018 Farm Bill, officially known as the Agriculture Improvement Act of 2018, is a comprehensive piece of legislation that governs agricultural and food policy in the United States. One of the key provisions of the 2018 Farm Bill is the legalization of industrial hemp, which is defined as cannabis plants with a delta-9 THC […]

THC 52

THC DEA Agriculture Law 52

NORML

JANUARY 17, 2019

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. . The agency ultimately rejected her decision.

Clinical Trials 223

Clinical Trials Legislation DEA Patients 223

Canna Law Blog

FEBRUARY 16, 2024

Griffen’s article is just one of many parsing the language of the 2018 Farm Bill and a 2023 DEA letter on the topic. See also: “ THCA and the DEA: Rod Breaks Down the Latest News ” from Rod Kight, an another attorney prominent in the space. I would say: “Someone over at DEA wrote a letter last year indicating that it’s not.

DEA 89

DEA Seed-To-Sale Hemp Concentrates 89

NORML

JANUARY 13, 2020

This Wednesday, January 15th, at 10 am EST, the House Energy and Commerce Subcommittee on Health will hold a legislative hearing entitled “Cannabis Policies for the New Decade.” Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA). Witnesses will be: Matthew J.

Legislation 180

Legislation Marijuana Policy DEA 180

Americans for Safe Access

APRIL 2, 2019

The Americans for Safe Access 2019 Unity Conference, themed The Price of Being a Medical Cannabis Patient, featured over a hundred patients from all over America visiting their representatives in Congress and the Senate to promote the Medical Cannabis Control Act of 2019. Which agency will have authority over medical cannabis policy?

Access 101

Access DEA Policy Patients 101

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. The INCBA supports lawyers in their practice of law as they serve all aspects of the cannabis and related industries. Hemp Industries Association v.

DEA 111

DEA Hemp Cultivation Advocacy 111

Canna Law Blog

JULY 26, 2023

Last week, a LinkedIn post by cannabis economist Beau Whitney caught my eye, because Beau said something pretty amazing. Bad policy and the new cannabinoids markets It always starts with policy. Pursuant to the 2018 Farm Bill, when a cannabis plant tests at or below 0.3% Could that be true? Mini hit list below.

Hemp 91

Hemp DEA THC Policy 91

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

JUNE 28, 2021

Drug Enforcement Agency (“DEA”). Given the alarming and noticeable increase in ayahuasca border seizures in 2020, the main intent of these initial requests was to see how many seizures happened that year and if the government had a specific policy regarding these seizures. Customs Border Patrol (“CBP”) and U.S. 562 [2011]).

DEA 97

DEA Blood Pressure Safety Policy 97